MK0140

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK0140, covering 2015-11-02 to 2015-11-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MK0140 in Diabetic Patients With Macular Edema (0140-001) [Phase 2]